Studies have found that injectable Toradol is equivalently effective, if not superior, when compared to corticosteroids.
What It Does
Toradol, like other NSAIDs, is helpful in decreasing the substances that cause inflammation.Accordingly, toradol is effective at reducing the signs and symptoms of inflammation, such as swelling, pain, and fevers.However, some research has demonstrated that Toradol is more effective than other NSAIDs for pain reduction from both inflammatory and non-inflammatory causes.
Forms
Most people who use Toradol receive it via injection. It may be given for up to five days in adults.
A tablet form of Toradol can be taken by mouth, and a nasal spray is also available. The drug may also be given intravenously (IV).
Side Effects/Risks
Toradol carries the same risk of side effects as do all NSAIDs. In clinical trials of NSAIDs, the most common side effects, occurring in greater than 10% of participants, are gastrointestinal problems including abdominal pain, vomiting, constipation, diarrhea, heartburn, and gas. Drowsiness, headaches, rashes and itching, anemia, hypertension, ringing in the ears, sweating, dizziness, and fluid retention were also reported.
Toradol can cause peptic ulcers, gastrointestinal bleeding, and performation of the stomach or intestines. Therefore, use of this medication is contraindicated for use by individuals with a history of these problems or who are at high-risk for developing these problems. Toradol is also contraindicated for individuals with serious kidney disease or at risk for it and for those at high risk for bleeding (including those at high risk for stroke).
A Word From Verywell
Toradol should only be taken for short-term management of severe pain as it can have some serious side effects. When taken properly, Toradol can treat short-term pain without the effects of stronger pain medications, such as a narcotics and opioids. If your healthcare provider prescribes it for you, make sure you ask about the best way to take it and what side effects to look out for.
